These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
447 related articles for article (PubMed ID: 32543726)
1. GABAergic dysfunction in excitatory and inhibitory (E/I) imbalance drives the pathogenesis of Alzheimer's disease. Bi D; Wen L; Wu Z; Shen Y Alzheimers Dement; 2020 Sep; 16(9):1312-1329. PubMed ID: 32543726 [TBL] [Abstract][Full Text] [Related]
2. Profiles of β-Amyloid Peptides and Key Secretases in Brain Autopsy Samples Differ with Sex and APOE ε4 Status: Impact for Risk and Progression of Alzheimer Disease. Nyarko JNK; Quartey MO; Pennington PR; Heistad RM; Dea D; Poirier J; Baker GB; Mousseau DD Neuroscience; 2018 Mar; 373():20-36. PubMed ID: 29331531 [TBL] [Abstract][Full Text] [Related]
3. TNF-α-mediated reduction in inhibitory neurotransmission precedes sporadic Alzheimer's disease pathology in young Trem2 Ren S; Breuillaud L; Yao W; Yin T; Norris KA; Zehntner SP; D'Adamio L J Biol Chem; 2021; 296():100089. PubMed ID: 33434745 [TBL] [Abstract][Full Text] [Related]
4. Roles of ApoE4 on the Pathogenesis in Alzheimer's Disease and the Potential Therapeutic Approaches. Sun YY; Wang Z; Huang HC Cell Mol Neurobiol; 2023 Oct; 43(7):3115-3136. PubMed ID: 37227619 [TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid β peptide. Hashimoto T; Serrano-Pozo A; Hori Y; Adams KW; Takeda S; Banerji AO; Mitani A; Joyner D; Thyssen DH; Bacskai BJ; Frosch MP; Spires-Jones TL; Finn MB; Holtzman DM; Hyman BT J Neurosci; 2012 Oct; 32(43):15181-92. PubMed ID: 23100439 [TBL] [Abstract][Full Text] [Related]
6. Regulation of Synaptic Amyloid-β Generation through BACE1 Retrograde Transport in a Mouse Model of Alzheimer's Disease. Ye X; Feng T; Tammineni P; Chang Q; Jeong YY; Margolis DJ; Cai H; Kusnecov A; Cai Q J Neurosci; 2017 Mar; 37(10):2639-2655. PubMed ID: 28159908 [TBL] [Abstract][Full Text] [Related]
7. Reduction of the expression of the late-onset Alzheimer's disease (AD) risk-factor Andrew RJ; De Rossi P; Nguyen P; Kowalski HR; Recupero AJ; Guerbette T; Krause SV; Rice RC; Laury-Kleintop L; Wagner SL; Thinakaran G J Biol Chem; 2019 Mar; 294(12):4477-4487. PubMed ID: 30692199 [TBL] [Abstract][Full Text] [Related]
8. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models. Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932 [TBL] [Abstract][Full Text] [Related]
10. ApoE isoforms and carboxyl-terminal-truncated apoE4 forms affect neuronal BACE1 levels and Aβ production independently of their cholesterol efflux capacity. Dafnis I; Raftopoulou C; Mountaki C; Megalou E; Zannis VI; Chroni A Biochem J; 2018 May; 475(10):1839-1859. PubMed ID: 29743204 [TBL] [Abstract][Full Text] [Related]
11. Beta-secretase-1 elevation in transgenic mouse models of Alzheimer's disease is associated with synaptic/axonal pathology and amyloidogenesis: implications for neuritic plaque development. Zhang XM; Cai Y; Xiong K; Cai H; Luo XG; Feng JC; Clough RW; Struble RG; Patrylo PR; Yan XX Eur J Neurosci; 2009 Dec; 30(12):2271-83. PubMed ID: 20092570 [TBL] [Abstract][Full Text] [Related]
12. β-Secretase-1 elevation in aged monkey and Alzheimer's disease human cerebral cortex occurs around the vasculature in partnership with multisystem axon terminal pathogenesis and β-amyloid accumulation. Cai Y; Xiong K; Zhang XM; Cai H; Luo XG; Feng JC; Clough RW; Struble RG; Patrylo PR; Chu Y; Kordower JH; Yan XX Eur J Neurosci; 2010 Oct; 32(7):1223-38. PubMed ID: 20726888 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease. Mattsson N; Groot C; Jansen WJ; Landau SM; Villemagne VL; Engelborghs S; Mintun MM; Lleo A; Molinuevo JL; Jagust WJ; Frisoni GB; Ivanoiu A; Chételat G; Resende de Oliveira C; Rodrigue KM; Kornhuber J; Wallin A; Klimkowicz-Mrowiec A; Kandimalla R; Popp J; Aalten PP; Aarsland D; Alcolea D; Almdahl IS; Baldeiras I; van Buchem MA; Cavedo E; Chen K; Cohen AD; Förster S; Fortea J; Frederiksen KS; Freund-Levi Y; Gill KD; Gkatzima O; Grimmer T; Hampel H; Herukka SK; Johannsen P; van Laere K; de Leon MJ; Maier W; Marcusson J; Meulenbroek O; Møllergård HM; Morris JC; Mroczko B; Nordlund A; Prabhakar S; Peters O; Rami L; Rodríguez-Rodríguez E; Roe CM; Rüther E; Santana I; Schröder J; Seo SW; Soininen H; Spiru L; Stomrud E; Struyfs H; Teunissen CE; Verhey FRJ; Vos SJB; van Waalwijk van Doorn LJC; Waldemar G; Wallin ÅK; Wiltfang J; Vandenberghe R; Brooks DJ; Fladby T; Rowe CC; Drzezga A; Verbeek MM; Sarazin M; Wolk DA; Fleisher AS; Klunk WE; Na DL; Sánchez-Juan P; Lee DY; Nordberg A; Tsolaki M; Camus V; Rinne JO; Fagan AM; Zetterberg H; Blennow K; Rabinovici GD; Hansson O; van Berckel BNM; van der Flier WM; Scheltens P; Visser PJ; Ossenkoppele R Alzheimers Dement; 2018 Jul; 14(7):913-924. PubMed ID: 29601787 [TBL] [Abstract][Full Text] [Related]
14. High Fat Diet Aggravates AD-Related Pathogenic Processes in APP/PS1 Mice. Gong X; Liang Z; Liu W; Zhao Y; Yang Y; Wu M; Shang J; Xiao Y; Mei Y; Su Q; Sun B; Bao J; Shu X Curr Alzheimer Res; 2021; 18(4):310-325. PubMed ID: 34212829 [TBL] [Abstract][Full Text] [Related]
15. α-Melanocyte stimulating hormone prevents GABAergic neuronal loss and improves cognitive function in Alzheimer's disease. Ma K; McLaurin J J Neurosci; 2014 May; 34(20):6736-45. PubMed ID: 24828629 [TBL] [Abstract][Full Text] [Related]
16. Amyloid β causes excitation/inhibition imbalance through dopamine receptor 1-dependent disruption of fast-spiking GABAergic input in anterior cingulate cortex. Ren SQ; Yao W; Yan JZ; Jin C; Yin JJ; Yuan J; Yu S; Cheng Z Sci Rep; 2018 Jan; 8(1):302. PubMed ID: 29321592 [TBL] [Abstract][Full Text] [Related]
18. Blocking the apoE/Aβ interaction ameliorates Aβ-related pathology in APOE ε2 and ε4 targeted replacement Alzheimer model mice. Pankiewicz JE; Guridi M; Kim J; Asuni AA; Sanchez S; Sullivan PM; Holtzman DM; Sadowski MJ Acta Neuropathol Commun; 2014 Jun; 2():75. PubMed ID: 24972680 [TBL] [Abstract][Full Text] [Related]
19. Epileptic Mechanisms Shared by Alzheimer's Disease: Viewed via the Unique Lens of Genetic Epilepsy. Kang JQ Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281185 [TBL] [Abstract][Full Text] [Related]
20. Amyloid-β protein (Aβ) Glu11 is the major β-secretase site of β-site amyloid-β precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis. Deng Y; Wang Z; Wang R; Zhang X; Zhang S; Wu Y; Staufenbiel M; Cai F; Song W Eur J Neurosci; 2013 Jun; 37(12):1962-9. PubMed ID: 23773065 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]